Meeting Highlights: The First Korean Breast Cancer Treatment Consensus Conference

被引：3

作者：

Han, Airi ^{[1
]}

Lee, Kyoung Eun ^{[2
]}

Lee, Hae Kyung ^{[3
]}

Park, Yeon Hee ^{[4
]}

Kim, Jeryoung ^{[5
]}

Kim, Sung-Won ^{[6
]}

Jung, Kyung Hae ^{[7
]}

Son, Byung-Ho ^{[8
]}

机构：

[1] Yonsei Univ, Wonju Coll Med, Dept Surg, Wonju, South Korea

[2] Ehwa Womans Univ Hosp, Dept Hematol Oncol, Seoul, South Korea

[3] Kwandong Univ, Coll Med, Dept Surg, Goyang, South Korea

[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea

[5] Chungnam Natl Univ Hosp, Dept Surg, Taejon, South Korea

[6] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea

[7] Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea

[8] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea

[9] Korean Breast Canc Soc, Seoul, South Korea

来源：

JOURNAL OF BREAST CANCER | 2014年 / 17卷 / 04期

关键词：

Breast neoplasms; Consensus; Practice guideline; Therapeutics; ASIAN-AMERICAN WOMEN; LYMPH-NODE DISSECTION; NEOADJUVANT CHEMOTHERAPY; AXILLARY DISSECTION; TRIAL; TRASTUZUMAB; RISK; PATTERNS; SURVIVAL; SURGERY;

D O I：

10.4048/jbc.2014.17.4.308

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The first Korean Breast Cancer Treatment Consensus Conference Expert Panel reviewed and endorsed new evidence on aspects of local and regional therapies and diagnostic procedures that support the conservative application of results from recent clinical trials. This conference clarified the barriers that limit the application of recent clinical trial results, such as questions about level of evidence, differences between the setting of clinical trials and that of daily clinical practice, and medical necessities and environment. Detailed decisions recommended for the treatment and diagnosis, according to the from the consensus conference, are recorded including details of the votes. These recommendations differed in the degree of support for clinical consideration of disease extent and host factors, medical necessities, and environment.

引用

页码：308 / 313

页数：6

共 28 条

[1]

[Anonymous], 2014, CLIN PRACT GUID ONC

[2] Axillary support in breast cancer: Survey practice in France [J].

Barranger, E. ;

Houvenaeghel, G. ;

Classe, J. -M. .

GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (7-8) :433-436

[3] Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].

Boughey, Judy C. ;

Suman, Vera J. ;

Mittendorf, Elizabeth A. ;

Ahrendt, Gretchen M. ;

Wilke, Lee G. ;

Taback, Bret ;

Leitch, A. Marilyn ;

Kuerer, Henry M. ;

Bowling, Monet ;

Flippo-Morton, Teresa S. ;

Byrd, David R. ;

Ollila, David W. ;

Julian, Thomas B. ;

McLaughlin, Sarah A. ;

McCall, Linda ;

Symmans, W. Fraser ;

Le-Petross, Huong T. ;

Haffty, Bruce G. ;

Buchholz, Thomas A. ;

Nelson, Heidi ;

Hunt, Kelly K. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461

[4] Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study [J].

Burstein, Harold J. ;

Keshaviah, Aparna ;

Baron, Ari D. ;

Hart, Ronald D. ;

Lambert-Falls, Rosemary ;

Marcom, P. Kelly ;

Gelman, Rebecca ;

Winer, Eric P. .

CANCER, 2007, 110 (05) :965-972

[5] Lapatinib Plus Capecitabine in Women with HER-2-Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial [J].

Cameron, David ;

Casey, Michelle ;

Oliva, Cristina ;

Newstat, Beth ;

Imwalle, Bradley ;

Geyer, Charles E. .

ONCOLOGIST, 2010, 15 (09) :924-934

[6] Breast cancer risk accumulation starts early: prevention must also [J].

Colditz, Graham A. ;

Bohlke, Kari ;

Berkey, Catherine S. .

BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (03) :567-579

[7] Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer [J].

de Boer, Maaike ;

van Deurzen, Carolien H. M. ;

van Dijck, Jos A. A. M. ;

Borm, George F. ;

van Diest, Paul J. ;

Adang, Eddy M. M. ;

Nortier, Johan W. R. ;

Rutgers, Emiel J. T. ;

Seynaeve, Caroline ;

Menke-Pluymers, Marian B. E. ;

Bult, Peter ;

Tjan-Heijnen, Vivianne C. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (07) :653-663

[8] Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial [J].

Galimberti, Viviana ;

Cole, Bernard F. ;

Zurrida, Stefano ;

Viale, Giuseppe ;

Luini, Alberto ;

Veronesi, Paolo ;

Baratella, Paola ;

Chifu, Camelia ;

Sargenti, Manuela ;

Intra, Mattia ;

Gentilini, Oreste ;

Mastropasqua, Mauro G. ;

Mazzarol, Giovanni ;

Massarut, Samuele ;

Garbay, Jean-Remi ;

Zgajnar, Janez ;

Galatius, Hanne ;

Recalcati, Angelo ;

Littlejohn, David ;

Bamert, Monika ;

Colleoni, Marco ;

Price, Karen N. ;

Regan, Meredith M. ;

Goldhirsch, Aron ;

Coates, Alan S. ;

Gelber, Richard D. ;

Veronesi, Umberto .

LANCET ONCOLOGY, 2013, 14 (04) :297-305

[9] Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort [J].

Gianni, Luca ;

Eiermann, Wolfgang ;

Semiglazov, Vladimir ;

Manikhas, Alexey ;

Lluch, Ana ;

Tjulandin, Sergey ;

Zambetti, Milvia ;

Vazquez, Federico ;

Byakhow, Mikhail ;

Lichinitser, Mikhail ;

Angel Climent, Miguel ;

Ciruelos, Eva ;

Ojeda, Belen ;

Mansutti, Mauro ;

Bozhok, Alla ;

Baronio, Roberta ;

Feyereislova, Andrea ;

Barton, Claire ;

Valagussa, Pinuccia ;

Baselga, Jose .

LANCET, 2010, 375 (9712) :377-384

[10] Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases [J].

Giuliano, Armando E. ;

McCall, Linda ;

Beitsch, Peter ;

Whitworth, Pat W. ;

Blumencranz, Peter ;

Leitch, A. Marilyn ;

Saha, Sukamal ;

Hunt, Kelly K. ;

Morrow, Monica ;

Ballman, Karla .

ANNALS OF SURGERY, 2010, 252 (03) :426-433

← 1 2 3 →